The DHSS will focus enforcement efforts on misbranded intoxicating cannabinoid products.
A letter from Richard Moore, deputy director and general counsel of the Missouri Department of Health and Senior Services indicates a change in enforcement priority for the DHSS in enforcing Governor Mike Parson recently imposed ban on intoxicating hemp products. DHSS began enforcement of the Governor’s executive order at the beginning of September. Reports indicated that 74 retail establishments were inspected, and in multiple case, business owners were forced to destroy inventory. The Missouri Hemp Trade Association (MHTA) also filed a lawsuit against the state in response to the executive order. The lawsuit cites 196.070.02, RSMo, which states that “A food shall not be considered adulterated solely for containing industrial hemp, or an industrial hemp commodity or product.”
In the letter, Moore expresses agreement with 196.070.02, RSMo. He wrote, “In regard to psychoactive cannabis products, the Department will focus its efforts on the identification of ‘misbranded’ products as that term is defined in Section 196.075, RSMo. If the Department identifies any such misbranded products, it will refer those products to the Missouri Attorney General’s Office for potential enforcement under the State’s Merchandising Practices Act, which, among other things, prohibits ‘[t]he act, use or employment by any person of any deception, fraud, false pretense, false promise, misrepresentation, unfair practice or the concealment, suppression, or omission of any material fact in 2 connection with the sale or advertisement of any merchandise in trade or commerce[.]’ To that end, the Department will aim to identify products that may violate the Merchandising Practices Act.”
Moore states that cannabis that have been embargoed will be released after 30 days. “He explains that, “All psychoactive cannabis products that the Department has tagged as an embargoed product under Chapter 196, RSMo, since August 1, 2024, will be referred to the Attorney General’s Office for evaluation of Missouri Merchandising Practices Act violations. The Department has no intention at this time to embargo additional psychoactive cannabis products as adulterated. Further, within 30 days after referral to the Attorney General’s Office, the Department will release all currently embargoed products and remove all embargo tags. Once embargo tags are removed, such product will not be subject to an embargo so long as there is no court order prohibiting its sale or ordering its destruction.”
He also clarified that the executive order only pertains to intoxicating products. “Hemp or cannabidol (CBD) products which are collected by extraction and have not been changed into a new substance, such as hemp protein powders, hemp milk, hemp flower, hemp teas or other drinks, CBD gummies, CBD drink additives, or foods with CBD, have not been embargoed to date,” wrote Moore.
MHTA is advocating for the release of embargoed products sooner than 30 days. “Our legal team is working closely with DHSS and state officials to explore ways to expedite the process, ensuring that your products can be sold as soon as possible,” wrote MHTA in a press release. “MHTA is committed to fighting for a quicker resolution, and we’re exploring all legal avenues to make it happen.”
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Work Smarter, Not Harder: How ASTM Standards for Cannabinoids Improve Your Operations
December 3rd 2024ASTM Standards D8557-24 and D8556-24, provide unified guidelines for GMP (Good Manufacturing Practices) and QMS (Quality Management Systems) in cannabis operations. These standards enhance compliance, product safety, and operational consistency across the industry for the benefit of operators, consumers, and other stakeholders in the industry.